Glenview Trust Co Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001691827
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2025 · 487 positions · Total reported value $6.31B · Top-10 concentration 35.4% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 42.3% · 32 new · 169 cut · 31 exited
Active Share (vs S&P 500): 46.6% · vs QQQ: 63.7% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): +0.0% · vs SPY -2.1% · Prev Value $7.23B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +0.7% · vs SPY -1.4% · Latest Value $7.42B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2025 13F filing, Glenview Trust Co disclosed 487 equity positions with a combined reported value of $6.31B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 35.4% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.
The largest disclosed positions as of Q3 2025 were NVDA ($603.08M), AAPL ($273.15M), MSFT ($242.01M). By sector, the heaviest allocations are Technology 31.6%, Consumer Discretionary 12.2%. Versus the prior quarter, allocation shifted toward Technology (+1.2pp), Other (+0.7pp) and away from Health Care (-0.6pp), Consumer Discretionary (-0.8pp).
Versus the prior quarter, Glenview Trust Co opened 32 new positions, trimmed 169 and fully exited 31, a turnover rate of 42.3% of positions. The portfolio's overlap with the prior quarter was 92% of names.
The largest new positions opened in Q3 2025 were JFLX ($98.24M), SRE ($513.70K), NDAQ ($462.50K).
Of the 31 positions fully exited versus the prior quarter, the largest were EMXC ($937.57K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2025)
- JFLX J P MORGAN EXCHANGE TRADED F · $98.24M
- SRE SEMPRA · $513.70K
- NDAQ NASDAQ INC · $462.50K
- CCI CROWN CASTLE INC · $351.22K
- HALO HALOZYME THERAPEUTICS INC · $274.29K
- FNDF Schwab Fundamental Intl Lg Co ETF · $265.45K
- AB ALLIANCEBERNSTEIN HOLDING LP U · $237.12K
- CBRE CBRE GROUP INC · $224.21K
Fully Exited (vs previous quarter)
- EMXC ISHARES MSCI · prev qtr: $937.57K
Insider Transactions (Form 4)
Latest Glenview Trust Co buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Glenview Trust Co is an SEC-registered 13F filer. As of Q2 2026 it reported 517 US equity positions with a combined value of $7.23B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 517 positions · $7.23B reported value (Q2 2026)
- Top 10 holdings = 34.7% of reported value
- Largest position: NVDA (NVIDIA CORPORATION) at 8.6%
- Average position size: $13.99M
Sector Tilt
- Information Technology 30.6%
- Consumer Discretionary 11.6%
- Health Care 8.8%
- (classified holdings cover 69% of value)
Quarterly Activity
- Q2 2026: 33 new, 177 added, 156 reduced, 16 exited
- 151 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
3.23M | $603.08M | 9.56% | Reduce | |
| 2 |
|
1.07M | $273.15M | 4.33% | Hold | |
| 3 |
|
467.25K | $242.01M | 3.84% | Hold | |
| 4 |
|
305.04K | $204.16M | 3.24% | Reduce | |
| 5 |
|
497.51K | $164.13M | 2.60% | Reduce | |
| 6 |
|
663.22K | $161.23M | 2.56% | Hold | |
| 7 |
|
1.17M | $152.60M | 2.42% | Reduce | |
| 8 |
|
190.81K | $145.59M | 2.31% | Hold | |
| 9 |
|
195.70K | $143.72M | 2.28% | Reduce | |
| 10 |
|
2.76M | $140.86M | 2.23% | Add | |
| 11 |
|
619.79K | $136.09M | 2.16% | Add | |
| 12 |
|
407.34K | $128.49M | 2.04% | Reduce | |
| 13 |
|
1.29M | $124.51M | 1.97% | Hold | |
| 14 |
|
158.97K | $105.90M | 1.68% | Add | |
| 15 |
|
1.96M | $98.24M | 1.56% | New | |
| 16 |
|
170.27K | $96.85M | 1.54% | Reduce | |
| 17 |
|
2.52M | $96.37M | 1.53% | Reduce | |
| 18 |
|
414.15K | $95.89M | 1.52% | Reduce | |
| 19 |
|
1.81M | $88.48M | 1.40% | Add | |
| 20 |
|
855.95K | $88.21M | 1.40% | Hold | |
| 21 |
|
289.52K | $81.42M | 1.29% | Reduce | |
| 22 |
|
679.19K | $80.71M | 1.28% | Add | |
| 23 |
|
97.87K | $77.94M | 1.24% | Hold | |
| 24 |
|
120.54K | $60.60M | 0.96% | Add | |
| 25 |
|
114.44K | $51.18M | 0.81% | Hold | |
| 26 |
|
190.57K | $47.89M | 0.76% | Add | |
| 27 |
|
220.33K | $47.55M | 0.75% | Add | |
| 28 |
|
302.89K | $46.54M | 0.74% | Hold | |
| 29 |
|
157.43K | $44.42M | 0.70% | Hold | |
| 30 |
|
484.38K | $44.28M | 0.70% | Add | |
| 31 |
|
602.08K | $43.51M | 0.69% | Add | |
| 32 |
|
244.54K | $37.97M | 0.60% | Hold | |
| 33 |
|
151.86K | $37.31M | 0.59% | Reduce | |
| 34 |
|
68.50K | $32.68M | 0.52% | Reduce | |
| 35 |
|
154.00K | $32.42M | 0.51% | Add | |
| 36 |
|
324.00K | $32.25M | 0.51% | Add | |
| 37 |
|
134.85K | $31.87M | 0.51% | Reduce | |
| 38 |
|
282.45K | $31.85M | 0.51% | Reduce | |
| 39 |
|
938.15K | $31.25M | 0.50% | Add | |
| 40 |
|
367.40K | $30.84M | 0.49% | Reduce | |
| 41 |
|
141.38K | $30.35M | 0.48% | Reduce | |
| 42 |
|
454.94K | $30.17M | 0.48% | Hold | |
| 43 |
|
439.70K | $30.08M | 0.48% | Reduce | |
| 44 |
|
96.97K | $29.47M | 0.47% | Reduce | |
| 45 |
|
100.03K | $29.39M | 0.47% | Add | |
| 46 |
|
119.40K | $29.08M | 0.46% | Hold | |
| 47 |
|
31.45K | $28.94M | 0.46% | Add | |
| 48 |
|
57.33K | $28.62M | 0.45% | Hold | |
| 49 |
|
83.12K | $28.38M | 0.45% | Hold | |
| 50 |
|
119.03K | $28.21M | 0.45% | Reduce | |
FAQ
What did Glenview Trust Co buy in 2025-Q3?
In its 2025-Q3 13F filing, Glenview Trust Co reported 487 equity positions worth $6.31B in aggregate; its largest disclosed positions were NVDA ($603.08M), AAPL ($273.15M), MSFT ($242.01M).
How large is Glenview Trust Co's portfolio?
Glenview Trust Co reported $6.31B of long equity holdings across 487 positions as of 2025-Q3. Top-10 holdings account for 35.4% of reported value.
What is Glenview Trust Co's investment style?
HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.